BASF to Enter Medical Foods Market in the US with DIEM Labs
BASF Corporation and Diem Labs, LLC. have entered into a distribution agreement to commercialize BASF’s first U.S. medical food product for the dietary management of patients with Non-Alcoholic Fatty Liver Disease (NAFLD).
November 3, 2017
1 Min Read
BASF Corporation and Diem Labs, LLC. have entered into a distribution agreement to commercialize BASF’s first U.S. medical food product for the dietary management of patients with Non-Alcoholic Fatty Liver Disease (NAFLD).
Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.
You May Also Like